Improved risk stratification for clinical trials of delirium - Authors' reply

Affiliations

¹ Outcomes After Critical Illness and Surgery Group, Johns Hopkins University, Baltimore MD, USA; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore MD, USA; Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore MD, USA. Electronic address: dale.needham@jhmi.edu.
² Outcomes After Critical Illness and Surgery Group, Johns Hopkins University, Baltimore MD, USA; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore MD, USA.
³ Division of Pulmonary and Critical Care Medicine, Harborview Medical Center, University of Washington, Seattle WA, USA.
⁴ Outcomes After Critical Illness and Surgery Group, Johns Hopkins University, Baltimore MD, USA; Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore MD, USA.
⁵ Department of Medicine, Pulmonary and Critical Care Division, Intermountain Medical Center, Murray UT, USA; Psychology Department and Neuroscience Center, Brigham Young University, Provo UT, USA; Center for Humanizing Critical Care, Intermountain Health Care, Murray UT, USA.

Comment

Dale M Needham et al. Lancet Respir Med. 2016 May.

. 2016 May;4(5):e18.

doi: 10.1016/S2213-2600(16)30030-3.

¹ Outcomes After Critical Illness and Surgery Group, Johns Hopkins University, Baltimore MD, USA; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore MD, USA; Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore MD, USA. Electronic address: dale.needham@jhmi.edu.
² Outcomes After Critical Illness and Surgery Group, Johns Hopkins University, Baltimore MD, USA; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore MD, USA.
³ Division of Pulmonary and Critical Care Medicine, Harborview Medical Center, University of Washington, Seattle WA, USA.
⁴ Outcomes After Critical Illness and Surgery Group, Johns Hopkins University, Baltimore MD, USA; Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore MD, USA.
⁵ Department of Medicine, Pulmonary and Critical Care Division, Intermountain Medical Center, Murray UT, USA; Psychology Department and Neuroscience Center, Brigham Young University, Provo UT, USA; Center for Humanizing Critical Care, Intermountain Health Care, Murray UT, USA.

No abstract available

Comment on

Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial.
Needham DM, Colantuoni E, Dinglas VD, Hough CL, Wozniak AW, Jackson JC, Morris PE, Mendez-Tellez PA, Ely EW, Hopkins RO. Needham DM, et al. Lancet Respir Med. 2016 Mar;4(3):203-12. doi: 10.1016/S2213-2600(16)00005-9. Epub 2016 Jan 29. Lancet Respir Med. 2016. PMID: 26832963 Free PMC article. Clinical Trial.
Improved risk stratification for clinical trials of delirium.
Salluh JI, de Souza-Dantas VC, Gusmao-Flores D. Salluh JI, et al. Lancet Respir Med. 2016 May;4(5):e17. doi: 10.1016/S2213-2600(16)30020-0. Lancet Respir Med. 2016. PMID: 27304559 No abstract available.